Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease, caused
by pathogenic variants mainly in sarcomere genes. 1, 2 Next generation sequencing (NGS) …

Background: A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary
artery disease/myocardial infarction (CAD/MI) in a large family has recently been described. …

Background: In around 40–60% of Hypertrophic Cardiomyopathy (HCM) cases pathogenic
variants are not identified. Our aim was to evaluate the possible association of lncRNAs with …

Background Debate regarding the prognosis of asymptomatic patients with Brugada syndrome
(BrS) is possibly affected by the selection bias of survivors of sudden cardiac arrest (SCA)…

Objetivo Analizar la relación de las concentraciones séricas de lipoproteína (a) con la edad
de presentación de la cardiopatía isquémica y la severidad angiográfica de la enfermedad …

Hypertrophic cardiomyopathy (HCM) is a very heterogeneous disease. Although primarily
caused by mutations in genes encoding sarcomeric proteins, other genes might explain that …

Introduction and objectives Hereditary pulmonary veno-occlusive disease (PVOD) has been
associated with biallelic mutations in EIF2AK4 with the recent discovery of a founder …

Hypertrophic cardiomyopathy is caused by mutations in genes encoding sarcomeric proteins.
Its variable phenotype suggests the existence of modifier genes. Myocyte enhancer factor (…

Long QT syndrome (LQTS) is an inherited (autosomal dominant) channelopathy associated
with susceptibility to ventricular arrhythmias due to malfunction of ion channels in …

Left ventricle non-compaction cardiomyopathy (LVNC) has gained great interest in recent
years, being one of the most controversial cardiomyopathies. There are several open debates, …